Ondine Biomedical Inc. EBITDA for the year ending December 31, 2023: USD -10.40 M

Ondine Biomedical Inc. EBITDA is USD -10.40 M for the year ending December 31, 2023, a -25.19% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Ondine Biomedical Inc. EBITDA for the year ending December 31, 2022 was USD -13.90 M, a -63.63% change year over year.
  • Ondine Biomedical Inc. EBITDA for the year ending December 31, 2021 was USD -38.23 M, a 234.59% change year over year.
  • Ondine Biomedical Inc. EBITDA for the year ending December 31, 2020 was USD -11.43 M, a 17.94% change year over year.
  • Ondine Biomedical Inc. EBITDA for the year ending December 31, 2019 was USD -9.69 M, a -15.30% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)